Middle East & North Africa | Antiretroviral therapy coverage (% of people living with HIV)
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy. Limitations and exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information. Statistical concept and methodology: Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. Antiretroviral therapy has led to huge reductions in death and suffering of people with advanced HIV infection.
Publisher
The World Bank
Origin
Middle East & North Africa
Records
63
Source
Middle East & North Africa | Antiretroviral therapy coverage (% of people living with HIV)
1960
1961
1962
1963
1964
1965
1966
1967
1968
1969
1970
1971
1972
1973
1974
1975
1976
1977
1978
1979
1980
1981
1982
1983
1984
1985
1986
1987
1988
1989
1990
1991
1992
1993
1994
1995
1996
1997
1998
1999
0.95208333 2000
1.19495213 2001
1.24111374 2002
2.29756326 2003
2.54235399 2004
3.15729209 2005
4.47017673 2006
5.07958478 2007
6.07392364 2008
7.63041765 2009
9.1676876 2010
11.30484245 2011
14.21928919 2012
16.94623265 2013
20.47926201 2014
24.86959628 2015
30.07796185 2016
34.37845863 2017
39.5468202 2018
42.63005929 2019
44.93857941 2020
47.53783306 2021
2022
Middle East & North Africa | Antiretroviral therapy coverage (% of people living with HIV)
Antiretroviral therapy coverage indicates the percentage of all people living with HIV who are receiving antiretroviral therapy. Limitations and exceptions: The limited availability of data on health status is a major constraint in assessing the health situation in developing countries. Surveillance data are lacking for many major public health concerns. Estimates of prevalence and incidence are available for some diseases but are often unreliable and incomplete. National health authorities differ widely in capacity and willingness to collect or report information. Statistical concept and methodology: Data on HIV are from the Joint United Nations Programme on HIV/AIDS (UNAIDS). Changes in procedures and assumptions for estimating the data and better coordination with countries have resulted in improved estimates of HIV and AIDS. Antiretroviral therapy has led to huge reductions in death and suffering of people with advanced HIV infection.
Publisher
The World Bank
Origin
Middle East & North Africa
Records
63
Source